Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Prospective study of relationship between cytomegalovirus pneumonia and viral load in renal transplant recipients

Ye, Q ; Luo, G ; He, X ; Zheng, W ; Zheng, L ; Dong, X ; Xu, X ; Nilsson-Ehle, Peter LU and Xu, Ning LU (2004) In Transplantation Proceedings 36(10). p.3036-3041
Abstract
The present study prospectively examined the relationship between cytomegalovirus interstitial pneumonia (CMV-IP) and viral load among 56 renal transplant recipients. We sought to identify the cutoff of viral load to predict CMV-IP. Blood samples were obtained weekly within the first 2 months and every second week during 2 to 6 months after kidney transplantations. A commercial real-time polymerase chain reaction (PCR)-method was applied to quantify CMV-DNA in plasma or in leukocytes. Among 54 renal transplant recipients who were analyzed for CMV-DNA in the blood (96.4%), 8 experienced CMV-IP (14.3%) and 2 died (3.6%). After kidney transplantation, CMV-DNA loads were near 0 in plasma before the week 4 and before the week 3 in leukocytes... (More)
The present study prospectively examined the relationship between cytomegalovirus interstitial pneumonia (CMV-IP) and viral load among 56 renal transplant recipients. We sought to identify the cutoff of viral load to predict CMV-IP. Blood samples were obtained weekly within the first 2 months and every second week during 2 to 6 months after kidney transplantations. A commercial real-time polymerase chain reaction (PCR)-method was applied to quantify CMV-DNA in plasma or in leukocytes. Among 54 renal transplant recipients who were analyzed for CMV-DNA in the blood (96.4%), 8 experienced CMV-IP (14.3%) and 2 died (3.6%). After kidney transplantation, CMV-DNA loads were near 0 in plasma before the week 4 and before the week 3 in leukocytes among both groups. From week 5 (week 4, in leukocytes), plasma CMV-DNA loads in the CMV-IP group increased, the peak value reached at week 8 in plasma and the week 9 in leukocytes. Whereas, the CMV-DNA loads both in plasma and in leukocytes in the non-CMV-IP group fluctuated at lower levels, those in plasma were significantly different between the 2 groups at the weeks 5, 7, and 9. For CMV-DNA in leukocytes, there were significant differences between 2 groups from week 6 to week 11. The present study demonstrated that dynamic determination of CMV-DNA may predict the occurrence of CMV-IP. Viral loads over 10(4) copies/mL plasma continuing for 3 weeks may serve as a cutoff to predict CMV-IP. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Transplantation Proceedings
volume
36
issue
10
pages
3036 - 3041
publisher
Elsevier
external identifiers
  • pmid:15686689
  • wos:000226765800039
  • scopus:21244458875
  • pmid:15686689
ISSN
0041-1345
DOI
10.1016/j.transproceed.2004.10.050
language
English
LU publication?
yes
id
d1c5506f-d9da-4bbd-b9b6-c985b746f31f (old id 254028)
date added to LUP
2016-04-01 11:35:24
date last changed
2022-01-26 07:20:42
@article{d1c5506f-d9da-4bbd-b9b6-c985b746f31f,
  abstract     = {{The present study prospectively examined the relationship between cytomegalovirus interstitial pneumonia (CMV-IP) and viral load among 56 renal transplant recipients. We sought to identify the cutoff of viral load to predict CMV-IP. Blood samples were obtained weekly within the first 2 months and every second week during 2 to 6 months after kidney transplantations. A commercial real-time polymerase chain reaction (PCR)-method was applied to quantify CMV-DNA in plasma or in leukocytes. Among 54 renal transplant recipients who were analyzed for CMV-DNA in the blood (96.4%), 8 experienced CMV-IP (14.3%) and 2 died (3.6%). After kidney transplantation, CMV-DNA loads were near 0 in plasma before the week 4 and before the week 3 in leukocytes among both groups. From week 5 (week 4, in leukocytes), plasma CMV-DNA loads in the CMV-IP group increased, the peak value reached at week 8 in plasma and the week 9 in leukocytes. Whereas, the CMV-DNA loads both in plasma and in leukocytes in the non-CMV-IP group fluctuated at lower levels, those in plasma were significantly different between the 2 groups at the weeks 5, 7, and 9. For CMV-DNA in leukocytes, there were significant differences between 2 groups from week 6 to week 11. The present study demonstrated that dynamic determination of CMV-DNA may predict the occurrence of CMV-IP. Viral loads over 10(4) copies/mL plasma continuing for 3 weeks may serve as a cutoff to predict CMV-IP.}},
  author       = {{Ye, Q and Luo, G and He, X and Zheng, W and Zheng, L and Dong, X and Xu, X and Nilsson-Ehle, Peter and Xu, Ning}},
  issn         = {{0041-1345}},
  language     = {{eng}},
  number       = {{10}},
  pages        = {{3036--3041}},
  publisher    = {{Elsevier}},
  series       = {{Transplantation Proceedings}},
  title        = {{Prospective study of relationship between cytomegalovirus pneumonia and viral load in renal transplant recipients}},
  url          = {{http://dx.doi.org/10.1016/j.transproceed.2004.10.050}},
  doi          = {{10.1016/j.transproceed.2004.10.050}},
  volume       = {{36}},
  year         = {{2004}},
}